Lawrence Knab
Surgical Oncology · Hershey, PANPI 1467786988
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,083 of the $1,626 with a category attached, or 66.6%. 6 manufacturers reported payments, led by Intuitive Surgical at 53.5% of the total. Reporting peaked in 2020 at $679 and has fallen 63.4% since, to $249 in 2023.
Across 25 payments — averaging $65.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$870
- Covidien LP$255
- Johnson & Johnson$241
- W. L. Gore & Associates, Inc.$138
- Coherus Oncology, Inc.$102
- Cardinal Health 414 LLC$20
What the payments were for
- Travel & lodging$54333%
- Food & beverage$1,08367%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 16 | $870 |
| Covidien LP | 2 | $255 |
| Johnson & Johnson | 3 | $241 |
| W. L. Gore & Associates, Inc. | 2 | $138 |
| Coherus Oncology, Inc. | 1 | $102 |
| Cardinal Health 414 LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$408
- Echelon Flex$111
- Parietene$106
How this compares
$1,626 in reported general payments places this provider in the 55th percentile of 78 surgical oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 16 | $30,193 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Hershey
- Charles ViningHershey$3K
- Karisa BeebeHershey$592
- Colette PameijerHershey$204
- Richard BleicherPhiladelphia$53K
- Catherine CarruthersSouthampton$17K
- Nestor EsnaolaPhiladelphia$17K
- Andrea PorpigliaPhiladelphia$11K
- William MoranoWynnewood$11K
- Matthew HoltzmanPittsburgh$11K
- Arvind SabesanWynnewood$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.